GEN0101
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for GEN0101, covering 2015-07-20 to 2019-01-30. Get the full timeline:
Most recent: Clinical Trial Update: Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII [Phase 2]